{"result": "(\"entity\"<|>NUTRITIONAL EVALUATION<|>EVENT<|>Nutritional evaluation refers to the systematic assessment of the nutritional status of individuals, particularly in neonates, to optimize their dietary intake.)\n##\n(\"entity\"<|>RANDOMIZED CONTROLLED TRIAL<|>EVENT<|>A randomized controlled trial is a scientific study that randomly assigns participants to receive either the treatment or a control, used to evaluate the effectiveness of interventions in preterm parenteral nutrition.)\n##\n(\"entity\"<|>SYSTEMATIC LITERATURE REVIEW<|>EVENT<|>A systematic literature review is a methodical and comprehensive literature synthesis that aims to summarize the existing evidence on a specific topic, such as preterm parenteral nutrition.)\n##\n(\"entity\"<|>CLINICAL TRIAL<|>EVENT<|>A clinical trial is a research study conducted with human participants to evaluate the effects and safety of medical strategies, treatments, or devices, particularly in the context of nutrition for preterm infants.)\n##\n(\"entity\"<|>GUIDELINES FOR NUTRITION<|>EVENT<|>Guidelines for nutrition provide evidence-based recommendations for the nutritional care of patients, including infants and children receiving parenteral nutrition.)\n##\n(\"entity\"<|>NUTRITION IN INFANCY<|>EVENT<|>Nutrition in infancy refers to the dietary practices and nutritional needs of infants, which are critical for their growth and development.)\n##\n(\"entity\"<|>PARENTERAL NUTRITION<|>EVENT<|>Parenteral nutrition is a medical method of providing nutrition to individuals through intravenous delivery, often used for patients who cannot eat or absorb food normally.)\n##\n(\"entity\"<|>ENTERAL NUTRITION<|>EVENT<|>Enteral nutrition is the delivery of nutrients directly into the gastrointestinal tract, often used for patients who can still digest food but cannot consume it orally.)\n##\n(\"entity\"<|>HYPOSPHATEMIA<|>EVENT<|>Hypophosphatemia is a medical condition characterized by low levels of phosphate in the blood, which can occur in preterm infants receiving parenteral nutrition.)\n##\n(\"entity\"<|>HYPOKALEMIA<|>EVENT<|>Hypokalemia is a medical condition characterized by low levels of potassium in the blood, which can be a risk for preterm infants receiving parenteral nutrition.)\n##\n(\"entity\"<|>VITAMIN DEFICIENCY<|>EVENT<|>Vitamin deficiency refers to the lack of essential vitamins in the diet, which can lead to various health issues, particularly in children receiving home parenteral nutrition.)\n##\n(\"entity\"<|>GLUTAMINE SUPPLEMENTATION<|>EVENT<|>Glutamine supplementation involves providing additional glutamine, an amino acid, to patients, particularly infants, to prevent morbidity and mortality in preterm infants.)\n##\n(\"entity\"<|>NUTRITIONAL INTERVENTIONS<|>EVENT<|>Nutritional interventions are strategies implemented to improve the nutritional status of individuals, especially in clinical settings for infants and children.)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: . Philadephia: Elsevier Saunders; 2015. p. 592-612.\n\n32. Uthaya S, Modi N. Practical preterm parenteral nutrition: systematic literature review and recommedations for practice. Early Hum Dev. 2014; 90:747-53.\n\n33. Uthaya S, Liu X, Babalis D, Doré CJ, Warwick J, Bell J, et al. Nutritional evaluation and optimisation in neonates: a randomized, double-blind controlled trial of amino acid regimen and intravenous lipid composition in preterm parenteral nutrition. Am J Clin Nutr. 2016; 103: 1443-52.\n\n34. Trivedi A, Sinn JK. Early versus late administration of amino acids in preterm infants receiving parenteral nutrition. Cochrane Database Syst Rev. 2013; 7:CD008771.\n\n35. Vlaardingerbroek H, Schierbeek H, Rook D, Vermeulen MJ, Dorst K, Vermes A, et al. Albumin synthesis in very low birth weight infants is enhanced by earlyparenteral lipid and high-dose amino acid administration. Clin Nutr. 2016; 35:344-50.\n\n36. Boubred F, Herlenius E, Bartocci M, Jonsson B, Vanpée M. Extremely preterm infants who are small for gestational age have a high risk of early hypophosphatemia and hypokalemia. Acta Paediatr. 2015; 104:1077-1083.\n\n37. Bonsante F, Iacobelli S, Latorre G, Rigo J, De Felice C, Robillard PY, et al. Initial amino acid intake influences phosphorus and calcium homeostasis in preterm infants-it is time to change the composition of the early parenteral nutrition. PLoS ONE. 2013; 8:e72880.\n\n38. Imura K, Okada A. Amino acid metabolism in pediatric patients. Nutrition.1998; 14: 143-8.\n\n39. Rigo J, De Curtis M. Parenteral nutrition in premature infants. En: Guandalini S, ed. Textbook of Pediatric Gastroenterology and Nutrition. London: Taylor and Francis; 2004. p. 619-38.\n\n40. Moe-Byrne T, Brown JV, McGuire W. Glutamine supplementation to prevent morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2016 Apr 18; 4:CD001457.\n\n41. Brown JV, Moe-Byrne T, McGuire W. Glutamine supplementation for young infants with severe\n---\n878      BLOQUE: NUTRICIÓN PEDIÁTRICA\n\ngastrointestinal disease. Cochrane Database Syst Rev. 2014; 15:CD005947.\n\n42. Pedrón Giner C, Martínez Costa C, Moreno Villares JM. Parenteral nutrition in infants and children. In: Watson RR, Grimble G, Preedy VR, Zibadi S, eds. Nutrition in infancy. London: Springer; 2013. p. 233-45.\n\n43. Aschner JL, Anderson A, Slaughter JC, Aschner M, Steele S, Beller A, et al. Neuroimaging identifies increased manganese deposition in infants receiving parenteral nutrition. Am J Clin Nutr. 2015; 102:1482-9.\n\n44. Martínez Costa C, Pedrón Giner C. Nutrición enteral y parenteral. En: Moro Serrano M, Málaga Guerrero S, Madero López L, eds. Cruz Tratado de Pediatría. 11 ed. Madrid: Panamericana; 2014. p. 1061-73.\n\n45. ASPEN Board of Directors and the Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr. 2002; suppl 1:1SA-138SA.\n\n46. Wessel J, Balint J, Crill C, Klotz K. Standards for specialized nutrition support: hospitalized pediatric patients. NCP. 2005; 20: 103-16.\n\n47. Diamanti A, Capriati T, Cardile S, Benedetti S, Francalanci P, Elia D. Fat-soluble vitamin deficiency in children with intestinal failure receiving home parenteral nutrition. J Pediatr Gastroenterol Nutr. 2014; 59:e46.\n\n48. Timmer JG, Schipper HG. Peripheral venous nutrition: the equal relevance of volume load and osmolarity in relation to phlebitis. Clin Nutr. 1991;10:71–5.\n\n49. Kuwahara T, Asanami S, Kubo S. Experimental infusion phlebitis: tolerance osmolality of peripheral venous endothelial cells. Nutrition. 1998; 14(6):496–501.\n\n50. Piper HG, De Silva NT, Amaral JG, Avitzur Y, Wales PW. Peripherally inserted central catheters for long-term parenteral nutrition in infants with intestinal failure. J Pediatr Gastroenterol Nutr. 2013; 56:578-581.\n\n51. Hellbock HJ, Motchnick PA, Ames BN. Toxic hydroperoxides in intravenous lipid emulsions used in preterm infants. Pediatrics. 1993; 91: 83-88\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>ELSEVIER SAUNDERS<|>ORGANIZATION<|>Elsevier Saunders is a publishing company known for its medical and scientific literature, including textbooks and journals.)\n##\n(\"entity\"<|>UTHAYA S<|>PERSON<|>Uthaya S is a researcher involved in studies related to preterm parenteral nutrition and has authored multiple publications in the field.)\n##\n(\"entity\"<|>MODI N<|>PERSON<|>Modi N is a co-author with Uthaya S on research regarding preterm parenteral nutrition.)\n##\n(\"entity\"<|>LIU X<|>PERSON<|>Liu X is a researcher who contributed to studies on nutritional evaluation in neonates.)\n##\n(\"entity\"<|>BABALIS D<|>PERSON<|>Babalis D is a researcher involved in clinical trials related to amino acid regimens in preterm nutrition.)\n##\n(\"entity\"<|>DORÉ CJ<|>PERSON<|>Doré CJ is a researcher who has co-authored studies on parenteral nutrition in infants.)\n##\n(\"entity\"<|>WARWICK J<|>PERSON<|>Warwick J is a researcher contributing to the field of pediatric nutrition.)\n##\n(\"entity\"<|>BELL J<|>PERSON<|>Bell J is a researcher involved in studies on nutrition in preterm infants.)\n##\n(\"entity\"<|>TRIVEDI A<|>PERSON<|>Trivedi A is a researcher who has published work on the administration of amino acids in preterm infants.)\n##\n(\"entity\"<|>Sinn JK<|>PERSON<|>Sinn JK is a co-author with Trivedi A on research comparing early and late amino acid administration.)\n##\n(\"entity\"<|>VLAARDINGERBROEK H<|>PERSON<|>Vlaardingerbroek H is a researcher focused on albumin synthesis in low birth weight infants.)\n##\n(\"entity\"<|>SCHIERBEEK H<|>PERSON<|>Schierbeek H is a researcher involved in studies on nutrition in preterm infants.)\n##\n(\"entity\"<|>ROOK D<|>PERSON<|>Rook D is a researcher contributing to studies on nutritional interventions in infants.)\n##\n(\"entity\"<|>VERMEULEN MJ<|>PERSON<|>Vermeulen MJ is a researcher involved in pediatric nutrition studies.)\n##\n(\"entity\"<|>DORST K<|>PERSON<|>Dorst K is a researcher who has co-authored studies on nutrition in preterm infants.)\n##\n(\"entity\"<|>VERMES A<|>PERSON<|>Vermes A is a researcher contributing to the field of pediatric nutrition.)\n##\n(\"entity\"<|>BOUBRED F<|>PERSON<|>Boubred F is a researcher focused on the health risks of extremely preterm infants.)\n##\n(\"entity\"<|>HERLENIUS E<|>PERSON<|>Herlenius E is a researcher involved in studies on preterm infant health.)\n##\n(\"entity\"<|>BARTOCCI M<|>PERSON<|>Bartocci M is a researcher contributing to studies on preterm nutrition.)\n##\n(\"entity\"<|>JONSSON B<|>PERSON<|>Jonsson B is a researcher involved in pediatric nutrition studies.)\n##\n(\"entity\"<|>VANPÉE M<|>PERSON<|>Vanpée M is a researcher focused on the health of preterm infants.)\n##\n(\"entity\"<|>RIGO J<|>PERSON<|>Rigo J is a researcher who has published work on parenteral nutrition in premature infants.)\n##\n(\"entity\"<|>DE CURTIS M<|>PERSON<|>De Curtis M is a co-author with Rigo J on pediatric gastroenterology and nutrition.)\n##\n(\"entity\"<|>MOE-BYRNE T<|>PERSON<|>Moe-Byrne T is a researcher involved in studies on glutamine supplementation in infants.)\n##\n(\"entity\"<|>BROWN JV<|>PERSON<|>Brown JV is a researcher who has co-authored studies on glutamine supplementation for infants.)\n##\n(\"entity\"<|>MCGUIRE W<|>PERSON<|>McGuire W is a researcher focused on nutrition in preterm infants.)\n##\n(\"entity\"<|>PEDRÓN GINER C<|>PERSON<|>Pedrón Giner C is a researcher involved in parenteral nutrition studies in infants and children.)\n##\n(\"entity\"<|>MARTÍNEZ COSTA C<|>PERSON<|>Martínez Costa C is a co-author with Pedrón Giner C on nutrition in infants.)\n##\n(\"entity\"<|>WATSON RR<|>PERSON<|>Watson RR is an editor involved in the publication of works on nutrition in infancy.)\n##\n(\"entity\"<|>GRIMBLE G<|>PERSON<|>Grimble G is an editor contributing to the field of nutrition.)\n##\n(\"entity\"<|>PREEDY VR<|>PERSON<|>Preedy VR is an editor involved in nutrition research.)\n##\n(\"entity\"<|>ZIBADI S<|>PERSON<|>Zibadi S is an editor contributing to works on nutrition in infancy.)\n##\n(\"entity\"<|>GUANDALINI S<|>PERSON<|>Guandalini S is an editor of a textbook on pediatric gastroenterology and nutrition.)\n##\n(\"entity\"<|>ASPEN BOARD OF DIRECTORS<|>ORGANIZATION<|>The ASPEN Board of Directors oversees guidelines for parenteral and enteral nutrition in patients.)\n##\n(\"entity\"<|>CLINICAL GUIDELINES TASK FORCE<|>ORGANIZATION<|>The Clinical Guidelines Task Force develops clinical guidelines for nutrition support in patients.)\n##\n(\"entity\"<|>JPEN J PARENTER ENTERAL NUTR<|>ORGANIZATION<|>JPEN is a journal focused on parenteral and enteral nutrition research.)\n##\n(\"entity\"<|>DIAMANTI A<|>PERSON<|>Diamanti A is a researcher focused on vitamin deficiency in children receiving home parenteral nutrition.)\n##\n(\"entity\"<|>CAPRIATI T<|>PERSON<|>Capriati T is a co-author with Diamanti A on studies related to pediatric nutrition.)\n##\n(\"entity\"<|>CARDILE S<|>PERSON<|>Cardile S is a researcher involved in studies on pediatric nutrition.)\n##\n(\"entity\"<|>BENEDICTI S<|>PERSON<|>Benedicti S is a researcher contributing to studies on pediatric nutrition.)\n##\n(\"entity\"<|>FRANCALANCI P<|>PERSON<|>Francalanci P is a researcher focused on pediatric nutrition.)\n##\n(\"entity\"<|>ELIA D<|>PERSON<|>Elia D is a researcher involved in studies on pediatric nutrition.)\n##\n(\"entity\"<|>TIMMER JG<|>PERSON<|>Timmer JG is a researcher focused on peripheral venous nutrition in infants.)\n##\n(\"entity\"<|>SCHIPPER HG<|>PERSON<|>Schipper HG is a researcher involved in studies on nutrition in pediatric patients.)\n##\n(\"entity\"<|>KUWAHARA T<|>PERSON<|>Kuwahara T is a researcher focused on experimental infusion phlebitis.)\n##\n(\"entity\"<|>ASANAMI S<|>PERSON<|>Asanami S is a researcher involved in studies on nutrition.)\n##\n(\"entity\"<|>KUBO S<|>PERSON<|>Kubo S is a researcher focused on nutrition in infants.)\n##\n(\"entity\"<|>PIPER HG<|>PERSON<|>Piper HG is a researcher involved in studies on parenteral nutrition in infants.)\n##\n(\"entity\"<|>DE SILVA NT<|>PERSON<|>De Silva NT is a researcher contributing to studies on pediatric nutrition.)\n##\n(\"entity\"<|>AMARAL JG<|>PERSON<|>Amaral JG is a researcher focused on nutrition in infants.)\n##\n(\"entity\"<|>AVITZUR Y<|>PERSON<|>Avitzur Y is a researcher involved in studies on pediatric nutrition.)\n##\n(\"entity\"<|>WALES PW<|>PERSON<|>Wales PW is a researcher focused on parenteral nutrition in infants.)\n##\n(\"entity\"<|>HELLBOCK HJ<|>PERSON<|>Hellbock HJ is a researcher involved in studies on intravenous lipid emulsions.)\n##\n(\"entity\"<|>MOTCHNICK PA<|>PERSON<|>Motchnick PA is a researcher focused on pediatric nutrition.)\n##\n(\"entity\"<|>AMES BN<|>PERSON<|>Ames BN is a researcher involved in studies on toxic substances in nutrition.)\n##\n(\"relationship\"<|>UTHAYA S<|>MODI N<|>Uthaya S and Modi N co-authored research on preterm parenteral nutrition<|>8)\n##\n(\"relationship\"<|>UTHAYA S<|>LIU X<|>Uthaya S and Liu X collaborated on studies related to nutritional evaluation in neonates<|>8)\n##\n(\"relationship\"<|>UTHAYA S<|>BABALIS D<|>Uthaya S and Babalis D worked together on clinical trials regarding amino acid regimens<|>8)\n##\n(\"relationship\"<|>UTHAYA S<|>DORÉ CJ<|>Uthaya S and Doré CJ co-authored studies on parenteral nutrition<|>8)\n##\n(\"relationship\"<|>UTHAYA S<|>WARWICK J<|>Uthaya S and Warwick J collaborated on pediatric nutrition research<|>8)\n##\n(\"relationship\"<|>UTHAYA S<|>BELL J<|>Uthaya S and Bell J worked together on studies related to nutrition in preterm infants<|>8)\n##\n(\"relationship\"<|>TRIVEDI A<|>Sinn JK<|>Trivedi A and Sinn JK co-authored research on amino acid administration in preterm infants<|>8)\n##\n(\"relationship\"<|>VLAARDINGERBROEK H<|>SCHIERBEEK H<|>Vlaardingerbroek H and Schierbeek H collaborated on studies regarding albumin synthesis in infants<|>8)\n##\n(\"relationship\"<|>RIGO J<|>DE CURTIS M<|>Rigo J and De Curtis M co-authored a textbook on pediatric gastroenterology and nutrition<|>8)\n##\n(\"relationship\"<|>MOE-BYRNE T<|>BROWN JV<|>Moe-Byrne T and Brown JV co-authored studies on glutamine supplementation<|>8)\n##\n(\"relationship\"<|>PEDRÓN GINER C<|>MARTÍNEZ COSTA C<|>Pedrón Giner C and Martínez Costa C collaborated on research regarding parenteral nutrition<|>8)\n##\n(\"relationship\"<|>WATSON RR<|>GRIMBLE G<|>Watson RR and Grimble G are editors contributing to works on nutrition in infancy<|>8)\n##\n(\"relationship\"<|>WATSON RR<|>PREEDY VR<|>Watson RR and Preedy VR are editors involved in nutrition research<|>8)\n##\n(\"relationship\"<|>WATSON RR<|>ZIBADI S<|>Watson RR and Zibadi S are editors contributing to works on nutrition in infancy<|>8)\n##\n(\"relationship\"<|>GUANDALINI S<|>RIGO J<|>Guandalini S and Rigo J are involved in pediatric gastroenterology and nutrition<|>8)\n##\n(\"relationship\"<|>DIAMANTI A<|>CAPRIATI T<|>Diamanti A and Capriati T co-authored studies on vitamin deficiency in children<|>8)\n##\n(\"relationship\"<|>TIMMER JG<|>SCHIPPER HG<|>Timmer JG and Schipper HG collaborated on studies regarding nutrition support in pediatric patients<|>8)\n##\n(\"relationship\"<|>KUWAHARA T<|>ASANAMI S<|>Kuwahara T and Asanami S are involved in research on nutrition and phlebitis<|>8)\n##\n(\"relationship\"<|>PIPER HG<|>DE SILVA NT<|>Piper HG and De Silva NT collaborated on studies regarding parenteral nutrition<|>8)\n##\n(\"relationship\"<|>PIPER HG<|>AMARAL JG<|>Piper HG and Amaral JG are involved in studies on nutrition in infants<|>8)\n##\n(\"relationship\"<|>PIPER HG<|>AVITZUR Y<|>Piper HG and Avitzur Y collaborated on studies regarding parenteral nutrition<|>8)\n##\n(\"relationship\"<|>PIPER HG<|>WALES PW<|>Piper HG and Wales PW are involved in studies on nutrition in infants<|>8)\n##\n(\"relationship\"<|>HELLBOCK HJ<|>MOTCHNICK PA<|>Hellbock HJ and Motchnick PA collaborated on studies regarding intravenous lipid emulsions<|>8)\n##\n(\"relationship\"<|>HELLBOCK HJ<|>AMES BN<|>Hellbock HJ and Ames BN are involved in studies on toxic substances in nutrition<|>8)\n<|COMPLETE|>"}]}